Patients with multiple sclerosis have higher levels of serum ghrelin

Neuroendocrinology Letters

Volumn 26, Issue 6, 2005, Pages 819-822

  Berilgen, M Said ^a   Bulut, Serpil ^a   Ustundag, Bilal ^a   Tekatas, Aslan ^a   Ayar, Ahmet ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Body mass index; Ghrelin; Immunity; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; GHRELIN; GLATIRAMER; INTERFERON BETA SERINE;

ADULT; AGE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE COURSE; DISEASE DURATION; FEMALE; GENDER; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; MALE; MULTIPLE SCLEROSIS; RADIOIMMUNOASSAY; RELAPSE;

EID: 33645015815     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW Jr, Taub DD. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest. 2004; 114:57-66.
2. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya 5, Carpenter R, Grossman AB, Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab. 2002; 87:2988
3. Habib KE, PW, Gold GP. Chrousos Neuroendocrinology of stress. Endocrinol Metab Clin North Am. 2001; 30:695-728
4. Hattori N, Saito T, Yagyu T, Jiang BH, Kitagawa K, Inagaki C. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab. 2001; 86:4284-4291.
5. Inui A. Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nat Rev Neurosci. 2001; 2:551-560.
6. Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB. Ghrelin-a hormone with multiple functions. Front Neuroendocrinol. 2004; 25:27-68.
7. Li WG, Gavrila D, Liu X, Wang L, Gunnlaugsson S, Stoll LL, McCormick ML, Sigmund CD, Tang C, Weintraub NL. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation. 2004; 109:2221-2226.
8. Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol. 1996; 6:259-274.
9. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001; 50:121-127.
10. Miller AE, Lublin FD, Coyle PK. Multiple sclerosis in clinical practice. Martin Dunitz Inc. London, 2003, pp. 19-29.
11. Olek MJ, Dawson DM. Multiple sclerosis and other inflammatory demyelinating diseases of the central nervous system. In: Bradley WG ed. Neurology in clinical practice 4th edition Elseiver Inc: Philadelphia; 2004. pp. 1631-1638.
12. Powell MB, Mitchell D, Lederman J, Buckmeier J, Zamvil SS, Graham M, Ruddle NH, Steinman L. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int Immunol. 1990; 2:539-544.
13. Sanna V, Di Giacomo A, La Cava A, Lechler RI, Fontana S, Zappacosta S, Matarese G. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest. 2003; 111:241-250.
14. Selmaj KW, Raine CS. Tumor necrosis factor-mediates myelin and oligodendrocyte damage in vitro. Ann Neurol. 1988; 23:339-346.
15. Sommer N, Martin R. The role of T cells and cytokines in the pathogenesis of multiple sclerosis In: Thompson AJ, Ed. Multiple sclerosis: clinical challenges and controversies. Martin Dunitz Inc: London; 1997. pp. 87-101.